Kyocera will transfer the assets into a new, wholly owned, California-based company to be named Kyocera Medical Technologies in March 2019. Kyocera manufactures medical products, including artificial joints and dental implants, primarily for the Japanese market. The company obtained 510(k) clearance for its artificial hip joints in 2017 and began selling them in the U.S. the following year.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.